Cost-Effectiveness Analysis of Sex-Stratified Plasmodium vivax Treatment Strategies Using Available G6PD Diagnostics to Accelerate Access to Radical Cure

Tafenoquine has been licensed for the single-dose radical cure of Plasmodium vivax in adults; however, it is only recommended in patients with > 70% of normal glucose-6-phosphate dehydrogenase (G6PD) activity. Because this may hinder widespread use, we investigated sex-based treatment strategies...

Descripción completa

Detalles Bibliográficos
Autores principales: Devine, Angela, Howes, Rosalind E., Price, David J., Moore, Kerryn A., Ley, Benedikt, Simpson, Julie A., Dittrich, Sabine, Price, Ric N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Tropical Medicine and Hygiene 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356471/
https://www.ncbi.nlm.nih.gov/pubmed/32372747
http://dx.doi.org/10.4269/ajtmh.19-0943

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356471/
https://www.ncbi.nlm.nih.gov/pubmed/32372747
http://dx.doi.org/10.4269/ajtmh.19-0943

Ejemplares similares